Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique

References

• Dahl SL, Ward JR. (1982). Pharmacology, clinical efficacy, and adverse effects of piroxicam, a new nonsteroidal anti-inflammatory agent. Pharmacotherapy, 2:80–9.
   PubMed Web of Science ®Google Scholar
• Mckellar QA, May SA, Lees P. (1991). Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: 2 Individual agents. J Small Anim Pract, 32:225–35.
   Web of Science ®Google Scholar
• Galbraith EA, Mckellar QA. (1991). Pharmacokinetics and pharmacodynamics of piroxicam in dogs. Vet Rec, 128:561–5.
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2006). Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol, 6:501–8.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ibuki R, . (2006). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. J Control Release, 112:51–6.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Majerik V, Charbit G, Badens E, Horvath G, Szokonya L, Bosc N, . (2007). Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J Supercrit Fluids, 40:101–10.
   Web of Science ®Google Scholar
• Prabhu S, Ortega M, Ma Ch. (2005). Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int. J Pharm, 301:209–16.
   Google Scholar
• Sumano H, Devizcaya A. (1996). Tolerance and clinical evaluation of piroxicam in dogs. Canine Pract, 21:16–9.
   Google Scholar
• Bjorkman DJ. (1996). Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med, 101:S25–S32.
   Google Scholar
• Chiou WL, Riegelman S. (1970). Oral absorption of griseofulvin in dogs: Increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci, 59:937–42.
   PubMed Web of Science ®Google Scholar
• Sekiguchi K, Obi N. (1961). Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull, 9:866–72.
   Web of Science ®Google Scholar
• Goldberg AH, Gibaldi M, Kamig JL. (1965). Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J Pharm Sci, 54:1145–8.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Reigelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281–302.
   PubMed Web of Science ®Google Scholar
• Ford JL. (1986). The current status of solid dispersions. Pharm Acta Helv, 61:69–88.
   PubMedGoogle Scholar
• Kawashima Y, Okumura M, Takenaka H. (1982). Spherical crystallization: Direct spherical agglomeration of salicylic acid crystals during crystallization. Science, 216:1127–8.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. (2003). Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol, 130:283–9.
   Web of Science ®Google Scholar
• Maghsoodi M, Hassan-zadeh D, Barzegar-jalali M, Nokhodchi A, Martin G. (2007). Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique. Drug Dev Ind Pharm, 33:1216–24.
   PubMed Web of Science ®Google Scholar
• Cui FD, Kawashima Y, Takeuchi H, Niwa T, Hino T. (1996). Preparation of controlled releasing acrylic polymer microparticles of acebutolol hydrochloride and microparticles with sodium alginate in a polymeric spherical crystallization system. Chem Pharm Bull, 44:837–42.
   Web of Science ®Google Scholar
• Maghsoodi M, Esfahani M. (2009). Preparation of microparticles of naproxen with Eudragit RS and Talc by spherical crystallization technique. Pharm Dev Technol, 14(4):442–50.
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Itoh A, Kawashima Y, Kiuchi K. (1994). Preparation of agglomerated crystals for direct tabletting and microencapsulation by the spherical crystallization technique with a continuous system. Pharm Res, 11:478–84.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Kakeuchi H, Hino T, Itoh Y. (1991). Preparation of multiple unit hollow microparticles (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vitro). J Control Release, 16:279–90.
   Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. (1993). Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with DL-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior. J Control Release, 25:89–98.
   Web of Science ®Google Scholar
• Kawashima Y. (1989). Spherical crystallization as a novel particle design technique for oral drug delivery system. Chin Pharm J, 41:163–72.
   Google Scholar
• Cui FD, Wang X, Yang MS, Pang XJ. (2001). Studies on the preparation of sustained-release microparticles by spherical crystallization technique. In: The 18th symposium on particulate preparations and designs, Japan: 209–14.
   Google Scholar
• Pilpel N. (1964). The flow properties of magnesia. J Pharm Pharmacol, 16:705–16.
   PubMed Web of Science ®Google Scholar
• Carr RL. (1965). Evaluation flow properties of solids. Chem Eng, 72:163–8.
   Google Scholar
• Carr RL. (1965). Classify flow properties of solids. Chem Eng, 72:69–72.
   Google Scholar
• Re MI, Biscans B. (1999). Preparation of microparticles of Ketoprofen with acrylic polymers by a quasi-emulsion solvent diffusion method. Powder Technol, 101:120–33.
   Web of Science ®Google Scholar
• Kachrimanis K, Nikolakakis I, Malamataris S. (2000). Spherical crystal agglomeration of ibuprofen by the solvent–change technique in presence of methacrylic polymers. J Pharm Sci, 89(2):250–8.
   PubMed Web of Science ®Google Scholar
• Zaniboni HC, Fell JT, Collett JH. (1995). Production and characterization of enteric beads. Int J Pharm, 125:151–5.
   Web of Science ®Google Scholar
• Thomopson CJ, Hansford D, Higgin S, Rostron C, Hutcheon CA, Munday DL. (2007). Evaluation of ibuprofen-loaded microparticles prepared from novel copolyesters. Int J Pharm, 329:53–61.
   PubMed Web of Science ®Google Scholar
• Yang MS, Cui F, You B, Fan Y, Wang L, Yue P, . (2003). Preparation of sustained-release nitrendipine microparticles with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method. Int J Pharm, 259:103–13.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. (1992). Hollow microparticles for use as a floating controlled drug delivery system in the stomach. J Pharm Sci, 81(2):135–40.
   PubMed Web of Science ®Google Scholar
• Gennaro AR. (1990). Remington's pharmaceutical sciences, XVIII ed. Easton, PA: Mack Publishing Company, 1116.
   Google Scholar
• Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. (1999). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm, 181:143–51.
   PubMed Web of Science ®Google Scholar
• Mihalic M. (1986). Piroxicam. In: Florey, K, ed. Analytical profiles of drug substances, London: Academic Press 15, 509–31.
   Google Scholar
• Vrecer F, Vrbinc M, Meden A. (2003). Characterization of piroxicam crystal modifications. Int J Pharm, 256:3–15.
   PubMed Web of Science ®Google Scholar
• Gao Y, Cui F, Guan Y, Yang L, Wang Y, Zhang L. (2006). Preparation of roxithromycin-polymeric microparticles by the emulsion solvent diffusion method for taste masking. Int J Pharm, 318:62–9.
   PubMed Web of Science ®Google Scholar
• Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. (1996). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm, 143:59–66.
   Web of Science ®Google Scholar
• Broman E, Khoo C, Taylor LS. (2001). A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water-soluble drug. Int J Pharm, 222:139–51.
   PubMed Web of Science ®Google Scholar
• Dordunoo SK, Ford JL, Rubinstein MH. (1991). Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or Gelucire 44/14 for liquid filling of hard gelatin capsules. Drug Dev Ind Pharm, 17:1685–713.
   Web of Science ®Google Scholar
• Passerini N, Perissutti B, Moneghini M, Voinovich D, Albertini B, Cavallari C, . (2002). Characterization of carmazepinegelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J Pharm Sci, 91:699–707.
   PubMed Web of Science ®Google Scholar
• Albertinia B, Passerinia N, González-Rodrı´guezb ML, Perissuttic B, Rodrigueza L. (2004). Effect of Aerosil on the properties of lipid controlled release microparticles. J Control Release, 100:233–46.
   PubMed Web of Science ®Google Scholar